AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,605,170 | -1.3% | 214,241 | +2.0% | 0.00% | 0.0% |
| Q2 2023 | $2,638,502 | -2.1% | 210,072 | -13.6% | 0.00% | 0.0% |
| Q1 2023 | $2,696,333 | -37.2% | 243,132 | -30.9% | 0.00% | -50.0% |
| Q4 2022 | $4,293,414 | +28.4% | 351,631 | +9.7% | 0.00% | +100.0% |
| Q3 2022 | $3,345,000 | +41.3% | 320,406 | +45.3% | 0.00% | 0.0% |
| Q2 2022 | $2,368,000 | +12.0% | 220,446 | -1.3% | 0.00% | 0.0% |
| Q1 2022 | $2,114,000 | -11.8% | 223,257 | +7.6% | 0.00% | 0.0% |
| Q4 2021 | $2,398,000 | +21.1% | 207,571 | +0.1% | 0.00% | 0.0% |
| Q3 2021 | $1,980,000 | +23.8% | 207,411 | +25.0% | 0.00% | 0.0% |
| Q2 2021 | $1,600,000 | -1.1% | 165,959 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $1,618,000 | -57.2% | 163,786 | +0.0% | 0.00% | 0.0% |
| Q4 2020 | $3,780,000 | +74.0% | 163,705 | +6.4% | 0.00% | 0.0% |
| Q3 2020 | $2,173,000 | -12.7% | 153,914 | -6.8% | 0.00% | 0.0% |
| Q2 2020 | $2,490,000 | +74.5% | 165,080 | +6.9% | 0.00% | 0.0% |
| Q1 2020 | $1,427,000 | -9.5% | 154,396 | -4.6% | 0.00% | 0.0% |
| Q4 2019 | $1,576,000 | +50.1% | 161,794 | +23.6% | 0.00% | 0.0% |
| Q3 2019 | $1,050,000 | -26.7% | 130,908 | +14.1% | 0.00% | 0.0% |
| Q2 2019 | $1,432,000 | +25.6% | 114,742 | +36.9% | 0.00% | 0.0% |
| Q1 2019 | $1,140,000 | +43.8% | 83,833 | +1.2% | 0.00% | 0.0% |
| Q4 2018 | $793,000 | -1.5% | 82,835 | +24.4% | 0.00% | 0.0% |
| Q3 2018 | $805,000 | -22.6% | 66,601 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,040,000 | -3.2% | 66,601 | -6.8% | 0.00% | 0.0% |
| Q1 2018 | $1,074,000 | +6.3% | 71,430 | +2.1% | 0.00% | 0.0% |
| Q4 2017 | $1,010,000 | -5.7% | 69,951 | -1.9% | 0.00% | 0.0% |
| Q3 2017 | $1,071,000 | +91.9% | 71,285 | +28.6% | 0.00% | – |
| Q2 2017 | $558,000 | +43.1% | 55,411 | +1.6% | 0.00% | – |
| Q1 2017 | $390,000 | +42.9% | 54,559 | -1.0% | 0.00% | – |
| Q4 2016 | $273,000 | -5.2% | 55,107 | +38.8% | 0.00% | – |
| Q3 2016 | $288,000 | +77.8% | 39,711 | +33.4% | 0.00% | – |
| Q2 2016 | $162,000 | -33.6% | 29,770 | 0.0% | 0.00% | – |
| Q1 2016 | $244,000 | -2.0% | 29,770 | +14.4% | 0.00% | – |
| Q4 2015 | $249,000 | -12.0% | 26,027 | +26.2% | 0.00% | – |
| Q3 2015 | $283,000 | +32.9% | 20,621 | +34.3% | 0.00% | – |
| Q2 2015 | $213,000 | – | 15,357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |